Document Detail


The imbalance of T helper 17/regulatory T cells and memory B cells during the early post-transplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor-based immunosuppression.
MedLine Citation:
PMID:  23205589     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is limited clinical research regarding the changes in peripheral lymphocyte subsets during the early post-operative period of liver transplantation. Serial changes of T cells and B cells in living donor liver transplantation (LDLT) recipients during the early post-transplantion period were prospectively investigated. From June 2010 to February 2011, 27 consecutive LDLT recipients were enrolled. Percentages of T helper type 1 (Th1; interferon-γ-producing), Th2 (interleukin-4-producing), Th17 (interleukin-17-producing), regulatory T (Treg; CD4(+) CD25(+) FoxP3(+) ), memory B (CD19(+) CD24(hi) CD38(-) ) and mature B (CD19(+) CD24(int) CD38(int) ) cells were measured using fluorescence-activated cell sorting. Patients were followed up for a median of 9.9 months (range 6.8-15.5 months) after transplantation. Serial monitoring of immunological profiles showed no significant suppression of Th1, Th2, Th17, mature B or memory B cells, whereas frequencies of Treg cells significantly decreased. Interleukin-17 production by central and effector memory cells was not suppressed during the early post-operative period. The continuous production of interleukin-17 by the memory T cells may contribute to the persistence of Th17 cells. This prospective study demonstrated that current immunosuppression maintained the effector T or memory B cells during the early post-transplantation period but significantly suppressed Treg cells. Serial immune monitoring may suggest clues for optimal or individualized immunosuppression during the early post-operative period in clinical practice.
Authors:
Hee Yeon Kim; Mi-La Cho; Joo Yeon Jhun; Jae Kyeong Byun; Eun-Kyung Kim; Ye Been Yim; Byung Ha Chung; Seung Kew Yoon; Si Hyun Bae; Dong Goo Kim; Chul Woo Yang; Jong Young Choi
Related Documents :
23373059 - The relevance of mast cells in oral squamous cell carcinoma.
22994589 - Enrichment of regulatory t cells in acutely rejected human liver allografts.
25130689 - An orthogonal click-chemistry approach to design poly(glycerol monomethacrylate)-based ...
23869359 - Novel cell-free regeneration of bone using stem cell-derived growth factors.
23525469 - Zoledronic acid negatively affects the expansion of in vitro activated human nk cells ...
23509159 - Identification of the chemokine ccl28 as a growth and survival factor for human hematop...
7875219 - Ovalbumin injected with complete freund's adjuvant stimulates cytolytic responses.
20836669 - Bendamustine in chronic lymphocytic leukemia and non-hodgkin's lymphoma.
22844709 - Influence of betulinic acid on lymphocyte subsets and humoral immune response in mice.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Immunology     Volume:  138     ISSN:  1365-2567     ISO Abbreviation:  Immunology     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-16     Completed Date:  2013-03-11     Revised Date:  2014-02-04    
Medline Journal Info:
Nlm Unique ID:  0374672     Medline TA:  Immunology     Country:  England    
Other Details:
Languages:  eng     Pagination:  124-33     Citation Subset:  IM    
Copyright Information:
© 2012 Blackwell Publishing Ltd.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
B-Lymphocytes / immunology*,  pathology
Calcineurin / antagonists & inhibitors*,  immunology
Cyclosporine / administration & dosage*
Female
Follow-Up Studies
Humans
Immunologic Memory / drug effects*
Immunosuppression / methods
Immunosuppressive Agents / administration & dosage*
Liver Transplantation*
Living Donors*
Male
Middle Aged
Postoperative Period
Prospective Studies
Retrospective Studies
T-Lymphocytes, Regulatory / immunology*,  pathology
Tacrolimus / administration & dosage*
Th1 Cells / immunology,  pathology
Th17 Cells / immunology*,  pathology
Th2 Cells / immunology,  pathology
Chemical
Reg. No./Substance:
0/Immunosuppressive Agents; 83HN0GTJ6D/Cyclosporine; EC 3.1.3.16/Calcineurin; WM0HAQ4WNM/Tacrolimus
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-educati...
Next Document:  Comparison of GC-MS and NMR for Metabolite Profiling of Rice Subjected to Submergence Stress.